Since Washington and Colorado became the first states to legalize recreational marijuana use in 2012, the number of retailers, processors and… Read More
Adaptive Biotechnologies has signed a $300 million collaborative licensing agreement with Genentech to develop highly personalized cancer therapies. In addition… Read More
Seattle-based biotech startup Kineta today received a leg-up in its efforts to kill cancerous tumors using the immune system. Kineta announced an… Read More
After a recent staff meeting at Seattle Children’s Hospital, several doctors gathered around the coffeemaker to discuss sedation protocols used… Read More
Seattle-based biotech firm Impel NeuroPharma closed its latest round of funding, bringing in $67.5 million to develop treatments for central… Read More
Pillsy has launched a subscription service that works alongside the Seattle-based startup’s smart pill bottles, reminding users to take their supplements… Read More
Sorting through and analyzing medical records is incredibly time-consuming, limiting the ability of patients, doctors and administrators to make connections and… Read More
